Meanwhile, statin treatment of ovarian cancer cell lines activated c-Jun N-terminal kinase (JNK) signaling and induced the pro-apoptotic protein, Bim, reduced c-Myc phosphorylation, and blocked Ras/Rho signaling (37, 57, 113). This evidence concerns the gene RHO and ovarian cancer.